When was Novagen Analytics founded?

Novagen Analytics was founded in 2015.

Where is Novagen Analytics located?

Novagen Analytics is headquartered in Cambridge, United States.

Is Novagen Analytics a funded company?

Novagen Analytics is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Novagen Analytics rank among its competitors?

Novagen Analytics ranks 368th amongst 374 active competitors, of which 124 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Caris Life Sciences, which secured $168M in Apr, 2025.

Who are the top competitors of Novagen Analytics?

Novagen Analytics' top competitors include Human Longevity, Juno Therapeutics and Caris Life Sciences. Among them, Caris Life Sciences secured the most recent funding round in April, 2025.

Novagen Analytics - 2026 Company Profile, Team & Competitors

Company Details

Novagen Analytics is a precision medicine company that offers an analytics engine which develops relationships between genomic variations and external environmental factors. The engine uses machine learning algorithms and inferencing techniques to make predictions that can help with individualized health care. The company which is yet to launch claims that applications can range from personalized medicine to pre-birth disease detection. According to the company its customers are individuals and healthcare providers looking to provide personalized care.

Key Metrics

Founded Year

2015

Location

Cambridge, United States

Stage

Deadpooled

Ranked

368^th among 374 active competitors

Similar Companies

Human Longevity & 525 more

View Novagen Analytics' full profile

Novagen Analytics has not raised any funding rounds yet.

The founders of Novagen Analytics are Anthony Badea and Parth Shah.

Here are the details of Novagen Analytics' key team members:

Anthony Badea: Co-Founder of Novagen Analytics.
Parth Shah: Co-Founder of Novagen Analytics.

View details of Novagen Analytics's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Novagen Analytics include Human Longevity, Juno Therapeutics and Caris Life Sciences. Here is the list of Top 10 competitors of Novagen Analytics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Human Longevity 2013, San Diego (United States), Series B	Provider of precision medicine, preventative health assessments, and longevity care	$409M	Celgene, General Electric & 20 others	76/100
2nd	Juno Therapeutics 2013, Seattle (United States), Acquired	Global biopharmaceutical company discovering, developing, and delivering innovative medicines	$317M	RA Capital Management, BB Biotech & 14 others	74/100
3rd	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Sixth Street, Coatue & 19 others	74/100
4th	UniQure 1998, Amsterdam (Netherlands), Public	Developer of gene-based therapies for patients with genetic or acquired diseases	$111M	Foresite Capital, Advent Life Sciences & 11 others	70/100
5th	Orchard Therapeutics 2015, London (United Kingdom), Acquired	Developer of gene therapies for treating rare diseases	$440M	Baillie Gifford, ORI Capital & 30 others	70/100
6th	Castle Biosciences 2008, Friendswood (United States), Public	Provider of diagnostic devices for treating cancer	$62M	Industry Ventures, Health Quest Capital & 9 others	70/100
7th	Bluebird Bio 1992, Cambridge (United States), Acquired	Developer of gene therapies for severe genetic and rare diseases	$136M	TVM Capital, Third Rock Ventures & 9 others	70/100
8th	Congenica 2013, Cambridge (United Kingdom), Acquired	Provider of a platform for clinical genome analytics for treating patients with genetic diseases	$81.9M	Tencent, IDO Investments & 39 others	68/100
9th	Geneoscopy 2015, St. Louis (United States), Series C	Developer of non-invasive biomarker tests for colorectal cancer	$219M	LightChain Capital, Cultivation Capital & 18 others	68/100
10th	ProQR Therapeutics 2012, Leiden (Netherlands), Public	Developer of RNA-based therapeutics for the treatment of genetic disorders such as inherited retinal disorders	$58M	Sofinnova Partners, Kreos Capital & 7 others	65/100
368th	Novagen Analytics 2015, Cambridge (United States), Deadpooled	Analytics engine that detects relations between genomic variations and environmental factors	-	-	21/100